Bison Wealth, LLC Bristol Myers Squibb CO Transaction History

Bison Wealth, LLC

$561 Million
Q3 2024

A detailed history of Bison Wealth, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Bison Wealth, LLC holds 7,629 shares of BMY stock, worth $425,927. This represents 0.07% of its overall portfolio holdings.

Number of Shares

7,629

Previous 8,052 5.25%

Holding current value

$425,927

Previous $334,000 17.96%

% of portfolio

0.07%

Previous 0.06%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 05, 2024	SELL	$39.66 - $51.75 $16,776 - $21,890	-423 Reduced 5.25%	7,629 $394,000
Q1 2024 May 10, 2024	BUY	$47.98 - $54.4 $14,537 - $16,483	303 Added 3.91%	8,052 $436,000
Q4 2023 Jan 30, 2024	BUY	$48.48 - $57.85 $66,950 - $79,890	1,381 Added 21.69%	7,749 $397,000
Q3 2023 Nov 13, 2023	SELL	$57.89 - $64.73 $66,457 - $74,310	-1,148 Reduced 15.27%	6,368 $369,000
Q2 2023 Aug 14, 2023	BUY	$63.71 - $70.74 $197,883 - $219,718	3,106 Added 70.43%	7,516 $480,000
Q4 2022 Feb 10, 2023	SELL	$68.48 - $81.09 $25,748 - $30,489	-376 Reduced 7.86%	4,410 $317,000
Q3 2022 Nov 14, 2022	BUY	$0.13 - $76.84 $44 - $26,048	339 Added 7.62%	4,786 $340,000
Q2 2022 Jul 22, 2022	SELL	$72.62 - $79.98 $2,832 - $3,119	-39 Reduced 0.87%	4,447 $342,000
Q1 2022 May 12, 2022	SELL	$61.48 - $73.72 $10,267 - $12,311	-167 Reduced 3.59%	4,486 $328,000
Q4 2021 Feb 02, 2022	BUY	$53.63 - $62.52 $11,476 - $13,379	214 Added 4.82%	4,653 $290,000
Q3 2021 Nov 03, 2021	SELL	$59.17 - $69.31 $15,857 - $18,575	-268 Reduced 5.69%	4,439 $263,000
Q2 2021 Aug 02, 2021	BUY	$61.91 - $67.42 $26,435 - $28,788	427 Added 9.98%	4,707 $315,000
Q1 2021 May 05, 2021	SELL	$59.34 - $66.74 $102,658 - $115,460	-1,730 Reduced 28.79%	4,280 $270,000
Q4 2020 Feb 11, 2021	BUY	$57.74 - $65.43 $7,332 - $8,309	127 Added 2.16%	6,010 $373,000
Q3 2020 Oct 16, 2020	SELL	$57.43 - $63.64 $15,678 - $17,373	-273 Reduced 4.43%	5,883 $355,000
Q2 2020 Aug 03, 2020	SELL	$54.82 - $64.09 $251,294 - $293,788	-4,584 Reduced 42.68%	6,156 $362,000
Q1 2020 May 04, 2020	SELL	$46.4 - $67.43 $859,049 - $1.25 Million	-18,514 Reduced 63.29%	10,740 $599,000
Q4 2019 Feb 05, 2020	SELL	$49.21 - $64.19 $54,475 - $71,058	-1,107 Reduced 3.65%	29,254 $1.88 Million
Q3 2019 Nov 04, 2019	SELL	$42.77 - $50.71 $727 - $862	-17 Reduced 0.06%	30,361 $1.54 Million
Q2 2019 Aug 05, 2019	BUY	$44.62 - $49.34 $928,408 - $1.03 Million	20,807 Added 217.4%	30,378 $1.38 Million
Q1 2019 May 09, 2019	BUY	$45.12 - $53.8 $95,925 - $114,378	2,126 Added 28.56%	9,571 $457,000
Q4 2018 Feb 08, 2019	SELL	$48.76 - $63.23 $19,504 - $25,292	-400 Reduced 5.1%	7,445 $387,000
Q3 2018 Nov 09, 2018	SELL	$55.19 - $62.25 $1,324 - $1,494	-24 Reduced 0.3%	7,845 $487,000
Q2 2018 Aug 09, 2018	BUY	$50.53 - $62.98 $2,172 - $2,708	43 Added 0.55%	7,869 $435,000
Q1 2018 May 08, 2018	SELL	$59.92 - $68.98 $2,576 - $2,966	-43 Reduced 0.55%	7,826 $495,000
Q4 2017 Jan 29, 2018	SELL	$59.94 - $65.35 $30,269 - $33,001	-505 Reduced 6.03%	7,869 $482,000
Q3 2017 Oct 27, 2017	BUY	$55.23 - $63.74 $462,496 - $533,758	8,374	8,374 $534,000

Others Institutions Holding BMY

# of Institutions

2,536

Shares Held

1.46B

Call Options Held

31.6M

Put Options Held

35M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $119B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bison Wealth, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bison Wealth, LLC with notifications on news.

Account